Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

SK Biopharmaceuticals, a South Korean pharmaceutical company, announced today that the first patient was dosed in a phase 2 clinical trial in the US for patients suffering with chronic constipation using their new chemical entity YKP10811.

17 Mar 2012

Deadly link between higher BMI and colorectal cancer

The American College of Gastroenterology (ACG) and the Campaign to End Obesity (CEO) are joining forces to highlight the potentially deadly link between higher Body Mass Index (BMI) and colorectal cancer.

16 Mar 2012

USPTO issues patent to iSonea's ultrasound-based cough detector

Medical technology company iSonea Ltd. today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent 2009/0216127 A1 covering its cough count technology in the field of acoustic monitoring of respiratory diseases.

15 Mar 2012

Scientists discover cells that chaperone food antigens in the intestine

With every meal, immune cells in the intestine stand like sentries at a citadel, turning away harmful bacteria but allowing vitamins and nutrients to pass. Now, researchers at Washington University School of Medicine in St. Louis have identified the cells that chaperone food antigens, or proteins, in the intestine so that the immune system doesn't mount an attack.

15 Mar 2012

Fecal transplantation effective treatment for recurrent C. difficile infection

Fecal transplantation through colonoscopy is an effective treatment for recurrent Clostridium difficile infection (CDI), according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association.

15 Mar 2012

Many children with Crohn's disease and IBD benefit from ImproveCareNow

Many children with Crohn's disease and ulcerative colitis who received treatment through ImproveCareNow, a national quality improvement and research network, ceased to have symptoms and no longer needed to take steroids for disease management.

13 Mar 2012

Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints

Pfizer Inc. announced today that data from a Phase 3 study of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and establishing a safety profile in children and adolescents aged 5 through 17 years.

12 Mar 2012

Korean FDA grants pre-market clearance for ETView's VivaSight‐SL airway management solutions

ETView today announced that the Korean Food and Drug Administration ("KFDA") has granted pre-market clearance for VivaSight‐SL. With KFDA clearance, ETView plans to immediately initiate market launch of VivaSight‐SL. ETView also announced a distribution agreement with ChinooMTech Company.

12 Mar 2012

Ovarian cancer – push for greater awareness

Women are being warned about ovarian cancer – mostly a silent killer, since many do not know what symptoms to look out for. Each year in the UK around 6,700 women are diagnosed with the disease and more than 4,000 women lose their lives.

12 Mar 2012

Tumors can be more complex than imagined earlier: Study

Researchers speculate that cancers may be more complex that they knew. And that's why a single tissue sample taken from a single tumor may not be the best way to figure out a course of treatment they claim.

11 Mar 2012

Five new genetic mutations linked with Crohn's disease in Ashkenazi Jews

In the largest study of its kind, researchers from Mount Sinai School of Medicine have discovered five new genetic mutations associated with Crohn's disease in Jews of Eastern European descent, also known as Ashkenazi Jews.

9 Mar 2012

Even low-dose nanoparticles could have big impact on long-term health

Nanoparticles are everywhere. From cosmetics and clothes, to soda and snacks. But as versatile as they are, nanoparticles also have a downside, say researchers at Binghamton University and Cornell University in a recent paper published in the journal Nature Nanotechnology. These tiny particles, even in low doses, could have a big impact on our long-term health.

9 Mar 2012

Doctor associated with MMR vaccine and autism link wins High Court appeal

Professor John Walker-Smith had been found guilty of professional misconduct following claims he took part in unapproved research that suggested links between the vaccine, bowel disease and autism. Professor Walker-Smith lost his license to practice in May 2010 along with Dr Andrew Wakefield, who led the research. A General Medical Council’s ‘fitness to practice’ panel found both men guilty of misconduct over the way the work was conducted after 217 days of deliberation – the longest disciplinary case in the body’s 150- year history.

8 Mar 2012

Dr. Falk Pharma, Lipid Therapeutics enter license agreement for LT-02 to treat UC

Dr. Falk Pharma GmbH and Lipid Therapeutics, a biotechnology company focused on novel treatments for inflammatory bowel disease, today announced that they have entered into a licensing agreement for the European rights to Lipid Therapeutics' lead product, LT-02, for ulcerative colitis.

8 Mar 2012

Colon cancer screening guidelines released

According to a new guidance statement from the American College of Physicians all adults should get screened for colon cancer once they get older to reduce their risk of dying from the nation's number two cancer killer.

7 Mar 2012

MTPC, Medicago partner to develop and commercialize three new vaccines

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the establishment of a strategic alliance with Mitsubishi Tanabe Pharma Corporation (MTPC) through the execution of a Master Research Collaboration Agreement.

6 Mar 2012

Make That Call campaign to promote colorectal cancer screening

Katie Couric, NewYork-Presbyterian and its Jay Monahan Center for Gastrointestinal Health, the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance (NCCRA), and ABC today announced the "Make That Call" campaign to promote colon cancer screening for National Colon Cancer Awareness Month.

6 Mar 2012

Mayo Clinic experts available to discuss latest colorectal cancer research and treatment

March is National Colorectal Cancer Awareness Month. Colon cancer is one of the most common and deadly cancers, and also one of the most preventable. Mayo Clinic experts are available to discuss the latest in colorectal cancer research, detection and treatment.

6 Mar 2012

Premature by 2 to 3 weeks may raise risk for health issues: Study

Premature babies have always thought to be at risk of health issues but till now the health prospects of babies born two to three weeks premature were considered similar to those who were born at full-term.

4 Mar 2012

SK Biopharmaceuticals' YKP3089 receives Korea Drug Development Fund

South Korean pharmaceutical company SK Biopharmaceuticals announced that the lead drug, YKP3089, from its drug development program for the treatment of refractory epilepsy, has been awarded funding from the Korea Drug Development Fund to support clinical development for the next three years.

3 Mar 2012